Shah Pritesh has filed 13 insider transactions across 1 company since January 2023.
Most recent transaction: a sale of 382 shares of NovoCure Ltd ($NVCR) on November 07, 2023.
Activity breakdown: 0 open-market purchases and 8 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 7, 2023 | NovoCure Ltd | $NVCR | Shah Pritesh | Chief Growth Officer | S | Ordinary Shares | 382 | $12.65 | 124,511.0000 | 0 | 0.31% | 0.00% |
| Sept. 1, 2023 | NovoCure Ltd | $NVCR | Shah Pritesh | Chief Growth Officer | S | Ordinary Shares | 273 | $21.82 | 124,893.0000 | 0 | 0.22% | 0.00% |
| June 30, 2023 | NovoCure Ltd | $NVCR | Shah Pritesh | Chief Growth Officer | A | Ordinary Shares | 367 | $35.28 | 125,166.0000 | 0 | 0.29% | 0.00% |
| March 3, 2023 | NovoCure Ltd | $NVCR | Shah Pritesh | Chief Growth Officer | S | Ordinary Shares | 1570 | $76.16 | 144,650.0000 | 0 | 1.07% | 0.00% |
| March 3, 2023 | NovoCure Ltd | $NVCR | Shah Pritesh | Chief Growth Officer | S | Ordinary Shares | 2942 | $76.16 | 141,708.0000 | 0 | 2.03% | 0.00% |
| March 3, 2023 | NovoCure Ltd | $NVCR | Shah Pritesh | Chief Growth Officer | S | Ordinary Shares | 16909 | $76.16 | 124,799.0000 | 0 | 11.93% | 0.00% |
| March 2, 2023 | NovoCure Ltd | $NVCR | Shah Pritesh | Chief Growth Officer | S | Ordinary Shares | 937 | $75.28 | 99,038.0000 | 0 | 0.94% | 0.00% |
| March 3, 2023 | NovoCure Ltd | $NVCR | Shah Pritesh | Chief Growth Officer | A | Ordinary Shares | 3936 | $0.00 | 102,974.0000 | 0 | 3.97% | 0.00% |
| March 3, 2023 | NovoCure Ltd | $NVCR | Shah Pritesh | Chief Growth Officer | A | Ordinary Shares | 43246 | $0.00 | 146,220.0000 | 0 | 42.00% | 0.00% |
| Feb. 28, 2023 | NovoCure Ltd | $NVCR | Shah Pritesh | Chief Growth Officer | A | Ordinary Shares | 19055 | $0.00 | 101,898.0000 | 0 | 23.00% | 0.00% |
| March 1, 2023 | NovoCure Ltd | $NVCR | Shah Pritesh | Chief Growth Officer | S | Ordinary Shares | 1923 | $76.36 | 99,975.0000 | 0 | 1.89% | 0.00% |
| Feb. 28, 2023 | NovoCure Ltd | $NVCR | Shah Pritesh | Chief Growth Officer | A | Options to Buy Ordinary Shares | 31691 | $76.97 | 31,691.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Shah Pritesh | Chief Commercial Officer | S | Ordinary Shares | 387 | $108.00 | 82,843.0000 | 0 | 0.46% | 0.00% |